<DOC>
	<DOCNO>NCT00287924</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , methotrexate , work different way stop growth tumor cell , either kill cell stop dividing . PURPOSE : This phase II trial study well high-dose methotrexate work treat young patient residual ependymoma .</brief_summary>
	<brief_title>High-Dose Methotrexate Treating Young Patients With Residual Ependymoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine activity high-dose methotrexate upfront-window therapy young patient residual ependymoma . Secondary - Assess reason primary surgery complete/incomplete patient . - Assess feasibility toxicity second-look surgery 3 course high-dose methotrexate case initial surgery incomplete . OUTLINE : This multicenter , open-label study . Patients receive high-dose methotrexate IV continuously 24 hour day 0 , 14 , 28 absence disease progression unacceptable toxicity . Patients proceed chemotherapy protocol UKCCSG-CNS-9204 . After completion study treatment , patient follow periodically 9 year . PROJECTED ACCRUAL : A total 29 patient accrue study .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm ependymoma , include follow histologic variant : Cellular Papillary Clearcell Tanycytic Anaplastic ( malignant ) ependymoma The following diagnosis exclude : Myxopapillary ependymoma Subependymomas Ependymoblastomas Primitive neuroectodermal tumor ( PNETs ) Other neuroepithelial tumor Choroid plexus tumor Germ cell tumor Residual measurable ependymoma maximal surgical resection , include secondlook surgery , deem necessary Has undergone surgical resection within past 3 week PATIENT CHARACTERISTICS : At least 3 month 3 year age Neutrophil count &gt; 1,000/mm^3 Platelet count &gt; 100,000/mm^3 Able tolerate chemotherapy No coexistent unrelated disease ( i.e. , renal hematological ) would preclude chemotherapy treatment PRIOR CONCURRENT THERAPY : See Disease Characteristics Recovered prior surgery No previous chemotherapy Previous steroid allow No previous radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>newly diagnose childhood ependymoma</keyword>
</DOC>